Transient, inhaled gene therapy with gamma interferon mitigates pathology induced by host response in a mouse model of tuberculosis.

MLA

Bharti, Reena, et al. “Transient, Inhaled Gene Therapy with Gamma Interferon Mitigates Pathology Induced by Host Response in a Mouse Model of Tuberculosis.” Tuberculosis (Edinburgh, Scotland), vol. 134, May 2022, p. 102198. EBSCOhost, https://doi.org/10.1016/j.tube.2022.102198.

APA

Bharti, R., Roy, T., Verma, S., Reddy, D. V. S., Shafi, H., Verma, K., Raman, S. K., Pal, S., Azmi, L., Singh, A. K., Ray, L., Mugale, M. N., & Misra, A. (2022). Transient, inhaled gene therapy with gamma interferon mitigates pathology induced by host response in a mouse model of tuberculosis. Tuberculosis (Edinburgh, Scotland), 134, 102198. https://doi.org/10.1016/j.tube.2022.102198

Chicago

Bharti, Reena, Trisha Roy, Sonia Verma, D V Siva Reddy, Hasham Shafi, Khushboo Verma, Sunil K Raman, et al. 2022. “Transient, Inhaled Gene Therapy with Gamma Interferon Mitigates Pathology Induced by Host Response in a Mouse Model of Tuberculosis.” Tuberculosis (Edinburgh, Scotland) 134 (May): 102198. doi:10.1016/j.tube.2022.102198.